GOCO vs MA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GOCO exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. The company is experiencing a catastrophic collapse in top-line performance with YoY revenue growth plummeting -96.80% and an operating margin of -252.92%. While the stock trades at a deep discount to book value (P/B 0.45) and sales (P/S 0.08), these appear to be value traps given the trajectory of the business. Despite a bullish analyst target of $4.70, the deterministic data suggests a company in a death spiral with a -99.4% five-year price return.
MA shows neutral fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
GOCO vs MA: Head-to-Head Comparison
This page compares GoHealth, Inc. (GOCO) and Mastercard Incorporated (MA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.